MedTrace Logo

Effects of a Mushroom Blend on Gastrointestinal Symptoms and the Microbiome

NCT07027462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-04-01

No results posted yet for this study

Summary

This study will investigate the efficacy of a mushroom blend to improve gastrointestinal symptoms and mood. It will also be determining if the mushroom blend has an effect on the gut microbiome and metabolomics.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Mushroom blend

A mushroom blend that is targeted to improve gastrointestinal symptoms.

OTHER

Placebo

Placebo product.

Sponsors & Collaborators

  • M2 Ingredients

    collaborator INDUSTRY

  • Substantiation Sciences, LLC

    collaborator UNKNOWN

  • University of South Carolina

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-16
Primary Completion
2025-12-30
Completion
2026-03-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07027462 on ClinicalTrials.gov